12:00 AM
Jan 07, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Synageva completes follow-on

Synageva BioPharma Corp. (NASDAQ:GEVA), Lexington, Mass.
Business: Endocrine/Metabolic, Infectious
Date completed: 1/3/13...

Read the full 37 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >